Positive Disruption
is our mission
At Mazen Animal Health we use the power of plants to produce orally delivered biologics. Our world class team is passionate about continuously improving the welfare of animals, those who care for them, and our planet. Through integrity, trust and transparency, we are committed to being a long-term partner to the animal health community.
We will never stop pushing the boundaries of what is possible.
Expansive Potential
in disease management
Our cross-species platform has the flexibility to impact swine, poultry, livestock, aquaculture, pets and wildlife, addressing a wide variety of diseases. Mazen’s platform has the potential to expand the $50 billion global animal health market while dramatically reducing losses, positively impacting our environment.
Mazen has leveraged molecular farming to develop plant-based vaccines that are orally dosed with animal feed. Replacing injectable vaccines will not only lower the cost of animal production, but also improve worker safety, animal welfare and biosecurity.
Mazen has already demonstrated efficacy with three products in two species – swine and poultry - and is currently navigating regulatory registration for commercialization.
A diverse team
with a shared passion
The Mazen team brings together biotechnology expertise, production and manufacturing know-how, animal vaccine experience, business acumen and entrepreneurial passion.
We are championed and advised by an experienced and diverse Board with a background in agriculture, industry, and investments.
Our Key Investors
